Clinical Trials Browser

Interventional × Ovarian Neoplasms × Therapeutics × Clear all

NCT07239622 2025-11-20

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Phase 2 Not yet recruiting

36 enrolled

Gynecologic

Ovarian Neoplasms

NCT00335491 2011-09-30

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

Phase NA Completed

49 enrolled

BreastGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Fatigue, Lung Neoplasms, Lymphoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Small Cell Lung Carcinoma